| Article
From the European Journal of Pain.
Background: Precise cannabis treatment dosing remains a major challenge, leading to physicians’ reluctance to prescribe medical cannabis.
Objective: To test the pharmacokinetics, analgesic effect, cognitive performance and safety effects of an innovative...
| Podcast
Despite the widespread acceptance of medicinal and recreational cannabis use internationally and domestically, marijuana remains federally illegal in the United States.
For this reason, there are significant legal implications to clinical practice. Clinicians are unprepared to answer questions...
| Article
The use of medical cannabis has garnered a lot of recent attention, especially as parts of the United States and Canada have legalized its use. While it has been studied in cancer and nerve pain, not much is known about the usage rate and its efficacy in managing chronic musculoskeletal (MSK) pain...
| Article
Newswise — Ziva Cooper, research director of the UCLA Cannabis Research Initiative, has been awarded a $3.9 million grant from the National Center for Complementary and Integrative Health at the NIH to study whether cannabis chemicals called terpenes can reduce the amount of opioid medication a...
| Article
Newswise — McMaster University researchers have identified an antibacterial compound made by cannabis plants that may serve as a lead for new drug development.
An interdisciplinary team of McMaster researchers found that the chemical compound, or cannabinoid, called cannabigerol (CBG) is not only...
| Video
>Senior faculty member Michael Clark offers some thoughts on engagement of medical marijuana in pain treatment. Are there lessons to be learned from our experience with opioids? Perhaps so…
| Article
Newswise — Residents of states where cannabis has been legalized are more likely to believe it has beneficial effects - including health benefits in treatment of pain and anxiety or depression, reports a survey study in the Journal of Addiction Medicine, the official journal of the American Society...
| Article
Newswise — Inhaled cannabis reduces self-reported headache severity by 47.3% and migraine severity by 49.6%, according to a recent study led by Carrie Cuttler, a Washington State University assistant professor of psychology.
The study, published online recently in the Journal of Pain, is the...
| Video
A perennial favorite among the sessions at PAINWeek is the exchange of perspectives by clinical pharmacy specialist and adjunct associate professor Jeffrey Fudin and Jeffrey Gudin, director of the pain management and palliative care center at Englewood Hospital. In this 2-part video, we offer some...
| Article
Newswise — A team of researchers at the University of Georgia will study how legalized medical cannabis affects people living with chronic pain.
To date, 34 states and the District of Columbia have adopted medical cannabis laws, or MCLs, which legalize either home cultivation or dispensary-based...